Sentence examples for formulation formulation from inspiring English sources

Forty milligram of the selected formulation (formulation 1), was sufficient to provide in vitro "therapeutic" concentrations of ibuprofen (8 μg/ml) up to 8 days.

Table 5 Assay results for pregabalin determination in capsule formulation Formulation Label claim (mg) Mean Recovery (mg) ± SDa Mean % Recoverya± SDa Pregabalin 75 (Torrent Pharmaceuticals) 75 74.61 ± 0.55 99.48 ± 0.73 aAverage of nine determinations, three each with starting powder amount equivalent to 30, 60 and 90 mg pregabalin.

These analytical methods are used to assess the concentration of test article in nonclinical formulation, formulation homogeneity and formulation stability in support of regulated nonclinical studies (for example: safety, toxicokinetic, and pharmacokinetic studies).

The dissolution profile of the best formulation (formulation F7) according to standard curve and R2 was choose and is shown in Figure 1, with appropriate release rate near zero order release kinetic.

The aim of this study was to investigate the effect of formulation on the pharmacokinetics of diclofenac in two sustained release formulations (formulation A and Voltaren SR®) after oral delivery.

Table 6 Short summary of the differences between Bertsimas' and Lin's formulations Formulation Objective CPU time Level of conservatism Feasible solution Type of uncertainty Model dimensions (K = no.

These analytical methods are used to assess the concentration of the test article in nonclinical formulations, formulation homogeneity, and formulation stability in support of regulated nonclinical studies (for example, safety, toxicokinetic, and pharmacokinetic studies).

The methods and tools described in this paper include: stabilized finite element formulations; formulations for flows with moving boundaries and interfaces; mesh update methods; iterative solution techniques for large nonlinear equation systems; and parallel implementation of these methods.

Between the copolymers, the 50 50 PLGA formulations (Formulations A and B) demonstrate a rapid absorption profile, while Formulations C and D indicate a more sustained absorption curve.

The mixture design type includes selected inner points corresponding to the three-component formulations (formulations containing wax, surfactant, and defoamer) and a cubic model equation to get a more accurate model of the responses.

Of the four formulations, Formulations A C show a much larger initial burst than Formulation D. The initial burst value at day 1 for Formulation D was around 7%%, nearly two to three times lower than the 13 20 % drug absorption seen with Formulations A C.